1122-58-3
Chemical Structure
4-Dimethylaminopyridine
- CAS No.: 1122-58-3
- Formula:C7H10N2
- Molecular Weight:122.17
IUPAC Name: N,N-dimethylpyridin-4-amine
InChIKey: VHYFNPMBLIVWCW-UHFFFAOYSA-N
SMILES: CN(C)C1=CC=NC=C1
Biological Activity: 4-Dimethylaminopyridine is an acyl transfer catalyst. 4-Dimethylaminopyridine is used for labeling and analysis of glycoproteins on the surface of living cells. 4-Dimethylaminopyridine reduces dyskinesia attacks[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
4-Dimethylaminopyridine | 99.99% | 4-Dimethylaminopyridine is an acyl transfer catalyst. 4-Dimethylaminopyridine is used for labeling and analysis of glycoproteins on the surface of living cells. 4-Dimethylaminopyridine reduces dyskinesia attacks. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-Dimethylaminopyridine (Standard) | ≥98% | 4-Dimethylaminopyridine (Standard) is the analytical standard of 4-Dimethylaminopyridine. This product is intended for research and analytical applications. 4-Dimethylaminopyridine is an acyl transfer catalyst. 4-Dimethylaminopyridine is used for labeling and analysis of glycoproteins on the surface of living cells. 4-Dimethylaminopyridine reduces dyskinesia attacks. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-(Dimethylamino)-1-methylpyridinium iodide | 4-(Dimethylamino)-1-methylpyridinium iodide is a biochemical reagent. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2-Dimethylaminophenol | 2-Dimethylaminophenol is an inhibitor of human glyoxalase 1 (GLO1). 2-Dimethylaminophenol disrupts metal binding by substituting the pyridine nitrogen donor with a dimethylamino group. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-(Dimethylamino)phenol | 99.75% | 4-(Dimethylamino)phenol is a potent cyanide antidote. 4-(Dimethylamino)phenol increases the extracellular lactate dehydrogenase (LDH) without markedly affecting gluconeogenesis. 4-(Dimethylamino)phenol cannot decreases the ATP content until the membrane becomes permeable to LDH. 4-(Dimethylamino)phenol’s toxicity is related to its reaction with glutathione and formation of covalent complexes, leading to impaired cellular function. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Dimethylaminophenol (Standard) | ≥98% | 3-Dimethylaminophenol (Standard) is the analytical standard of 3-Dimethylaminophenol. This product is intended for research and analytical applications. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-Methoxypyridine | 99.92% | 4-Methoxypyridine is a biochemical reagent that can be used as a biological material or organic compound for life science related research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-(Dimethylamino)phenol hydrochloride | 4-(Dimethylamino)phenol hydrochloride is a potent cyanide antidote. 4-(Dimethylamino)phenol hydrochloride binds to hemoglobin, and form methemoglobin. 4-(Dimethylamino)phenol hydrochloride can be used in cyanide poisoning research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-Dimethylaminopyridine N-oxide | 98.14% | 4-Dimethylaminopyridine N-oxide (p-Dimethylaminopyridine N-oxide) is an Efficient Oxidizing Agent for Alkyl Halides. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
p-Dimethylaminobenzaldehyde | 99.88% | p-Dimethylaminobenzaldehyde (4-Dimethylaminobenzaldehyde) can be used as a chromogenic reagent or as an absorbent agent for heavy metal ions. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Hayashi T, et al. Semisynthetic lectin-4-dimethylaminopyridine conjugates for labeling and profiling glycoproteins on live cell surfaces. J Am Chem Soc. 2013 Aug 21;135(33):12252-8. [Content Brief]
- [2]. Weisz CJ, et al. Potassium channel blockers inhibit the triggers of attacks in the calcium channel mouse mutant tottering. J Neurosci. 2005 Apr 20;25(16):4141-5. [Content Brief]